Helicobacter pylori Eradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial

Background Helicobacter pylori infection is a substantial public health problem and plays etiological role in the pathogenesis of many gastroduodenal disorders. The addition of ecabet sodium is proven to improve the efficacy of the standard triple therapy. Our aim was to assess the efficacy and safe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Helicobacter (Cambridge, Mass.) Mass.), 2012-12, Vol.17 (6), p.458-465
Hauptverfasser:	Liang, Jie, Li, Jun, Han, Ying, Xia, Jielai, Yang, Yunsheng, Li, Wen, Zhang, Shutian, Wu, Yongdong, Yuan, Yaozong, Li, Zhaoshen, Du, Yiqi, Chen, Minhu, Chen, Baili, Jiang, Bo, Bai, Yang, Wen, Qinsheng, Wu, Kaichun, Fan, Daiming
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects bismuth-containing quadruple therapy Breath Tests China Cities Drug Therapy, Combination - adverse effects Drug Therapy, Combination - methods ecabet sodium-containing quadruple therapy Female Helicobacter Infections - drug therapy Helicobacter pylori Helicobacter pylori eradication Humans Male Middle Aged Treatment Outcome Urea - analysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!